Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement

Acta Dermato-Venereologica

Volumn 79, Issue 4, 1999, Pages 268-273

  Lu, S ^a   Tiekso, J ^a   Hietanen, S ^a   Syrjanen K ^a   Havu, V K ^a   Syrjanen S ^a  

^a NONE

Author keywords

Actinic keratosis; Cell cycle proteins; Extragenital Bowen's disease; Human papillomavirns; Keratoacanthoma; Squamous cell carcinoma; Verruca

Indexed keywords

CELL CYCLE PROTEIN; CYCLINE; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53; VIRUS DNA;

ACTINIC KERATOSIS; ARTICLE; BOWEN DISEASE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPLICATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KERATOACANTHOMA; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; SKIN CARCINOMA; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; KERATOSIS; KI-67 ANTIGEN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN; SKIN DISEASES; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; WARTS;

EID: 0032968189     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750010634     Document Type: Article

References (44)

1. 1. Bishop JM. The molecular genetics of cancers. Science 1987; 235: 305-311.
2. 2. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993; 329: 1318-1327.
3. 3. Pines J. p21 inhibits cyclin shock. Nature 1994; 369: 520-521.
4. 4. Linzer DI, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979; 17: 43-52.
5. 5. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
6. 6. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-526.
7. 7. Sim CS, Slater S, Mckee PH. Mutant p53 expression in solar keratosis: an immunohistochemical study. J Cutan Pathol 1992; 19: 302-308.
8. 8. Hollstein M, Sidransky D, Vogelstein B, Harris CC, p53 mutations in human cancers. Science 1991; 253: 49-53.
9. 9. Chang F, Syrjänen S, Kurvinen K, Syrjänen K. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 1993; 88: 174-186.
10. 10. el-Diery WS, Tokino T, Velculescu VE. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
11. 11. Dulic V, Kaufmann WK, Wilson SJ. p53-dependent inhibitin of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994; 76: 1013-1023.
12. 12. Harper JW, Adami GR, Wei N. The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
13. 13. Strausfeld UP, Howell M, Rempel R, Maller JL, Hunt T, Blow JJ. Cip1 blocks the initiation of DNA replication in xenopus extracts by inhibition of cyclin-dependent kenases. Curr Biol 1994; 4: 876-883.
14. 14. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574-578.
15. 15. Michieli P, Marcio C, Lin D, Chechid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-3395.
16. 16. Geary WA, Cooper PH. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. J Cutan Pathol 1992; 19: 458-468.
17. 17. Demeter LM, Stoler MH, Broker TR, Chow LT. Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Human Pathol 1994; 25: 343-348.
18. 18. Celis JE, Madsen P, Celis A. Cylin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathways leading to DNA replication and cell division. FEBS Let 1987; 220: 1-7.
19. 19. Bravo R, Frank R, Blumdell PA, Macdonald-Bravo H. Cylin/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515-517.
20. 20. Tan CK, Sullivan K, Li X, et al. Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxiliary protein for DNA polymerase delta. Nucleic Acid Res 1987; 15: 9299-9308.
21. 21. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
22. 22. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867-873.
23. 23. Yu CCW, Woods AL, Levison DA. The application of immunohistochemistry in assessment of cellular proliferation. In: Assessment of Cell Proliferation in Clinical Practice. Hall PA, Levison DA, Wright NA, editors. Heidelberg; Springer-Verlag, 1992: 141-159.
24. 24. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus type 16 and 18 E6 protein with p53. Science 1990; 248: 76-79.
25. 25. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
26. 26. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992; 26: 467-484.
27. 27. Lu S, Syrjänen K, Havu VK, Syrjänen S. No evidence of human papillomavirus DNA in actinic keratosis. Arch Dermatol Res 1995; 287: 649-651.
28. 28. Lu S, Syrjänen K, Havu VK, Syrjänen S. Known HPV types have no association with keratoacanthomas. Arch Dermatol Res 1996; 288: 129-132.
29. 29. Lu S, Syrjänen K, Havu VK, Syrjänen S. Expression of PCNA is associated with the presence of HPV DNA in skin warts. Arch Dermatol Res 1996; 289: 35-39.
30. 30. Lu S, Syrjänen K, Havu VK, Syrjänen S. Failure to demonstrate human papillomavirus (HPV) involvement in Bowen's disease of the skin. Arch Dermatol Res 1996; 289: 40-45.
31. 35S-labelled human papillomavirus (HPV) DNA probes. J Virol Methods 1988; 19: 225-238.
32. 32. Kallio P, Syrjänen S, Tervahauta A, Syrjänen K. A simple isolation of DNA from formalin-fixed, paraffin-embedded samples for PCR. J Virol Methods 1991; 35: 39-47.
33. 33. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
34. 34. Broker TR, Chow LT, Chin MT. A molecular portrait of human papillomavirus carcinogenesis. Cancer Cells 1989; 7: 197-208.
35. 35. Stoler MH, Whitbeck A, Wolinsky SM, Broker TR, Chow LT, Howett MK. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J Virol 1990; 64: 3310-3318.
36. 36. Stoler MH, Wolinsky SM, Whilbeck A. Differentiation-linked human papillomavirus type 6 and 11 transcription in genetal condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989; 172: 331-340.
37. 37. Tsurimoto T, Melendy T, Stillman B. Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin. Nature 1990; 346: 534-539.
38. 38. Zhang H, Hannon GJ, Beach. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994; 8: 1750-1758.
39. 39. Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387-400.
40. 40. Boon ME, Howard CV, van Velzen D. PCNA independence of KI-67 expression in HPV infection. Cel Biol Int 1993; 17: 1001-1004.
41. 41. Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, et al. Increased levels of p21 WAF1/Cip1 in human brain tumors. Oncogene 1995; 11: 2021-2028.
42. 42. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-1602.
43. 43. Nylander K, Stenling R, Gustafsson H, Zackrisson B, Roos G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 1994; 75: 87-93.
44. 44. Szekeres G, de Giacomoni P. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections. Acta Derm Venereol (Stockh) 1994; 74: 95-97.